Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis

Annals of Surgery

Volumn 259, Issue 1, 2014, Pages 72-81

  Kim, Kyung Won ^a,b   Park, Seong Ho ^a   Pyo, Junhee ^c   Yoon, Soon Ho ^d   Byun, Jae Ho ^a   Lee, Moon Gyu ^a   Krajewski, Katherine M ^b   Ramaiya, Nikhil H ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d Seoul National University Hospital   (South Korea)

Author keywords

Branch duct; Consensus guidelines; Intraductal papillary mucinous neoplasm; Meta analysis; Pancreas

Indexed keywords

AGE; ARTICLE; BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DILATATION; EMBASE; ENDOSCOPIC ECHOGRAPHY; EXCISION; GENDER; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DUCT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW;

AGED; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84891630068     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31829385f7     Document Type: Article

References (56)

1. Waters JA, Schmidt CM. Intraductal papillary mucinous neoplasm-when to resect? Adv Surg. 2008;42:87-108.
2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms andmucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
3. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-197.
4. Bassi C, Sarr MG, Lillemoe KD, et al. Natural history of intraductal papillary mucinous neoplasms (IPMN): Current evidence and implications for management. J Gastrointest Surg. 2008;12:645-650.
5. Lai ECH, Lau WY. Intraductal papillary mucinous neoplasms of the pancreas. Surgeon. 2005;3:317-324.
6. Liu D, Li F, Josefin BW, et al. Intraductal papillary mucinous neoplasms of the pancreas: Diagnosis and management. Eur J Gastroenterol Hepatol. 2010;22:1029-1038.
7. Longnecker DS, Adler G, Hruban RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2000:237-241.
8. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
9. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ. 2003;327:557-560.
10. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
11. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-Analysis. Biometrics. 2000;56:455-463.
12. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: Data-Analytic approaches and some additional considerations. Stat Med. 1993;12:1293-1316.
13. Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58:982-990.
14. Choi BS, Kim TK, Kim AY, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas:MR cholangiopancreatography and MR angiography. Korean J Radiol. 2003;4:157-162.
15. Irie H, Honda H, Aibe H, et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am J Roentgenol. 2000;174:1403-1408.
16. Tan L, ZhaoY-E,Wang D-B, et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography. World J Gastroenterol. 2009;15:4037-4043.
17. YamaoK,OhashiK,Nakamura T, et al. Evaluation of various imagingmethods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas. Hepatogastroenterology. 2001;48:962-966.
18. Zhang J,Wang P-J, Yuan X-D. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm. Eur J Radiol. 2010;73:96-101.
19. Cellier C, Cuillerier E, Palazzo L, et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and longterm outcome in a large surgical series. Gastrointest Endosc. 1998;47:42-49.
20. Kawamoto S, Lawler LP,HortonKM, et al.MDCT of intraductal papillary mucinous neoplasm of the pancreas: Evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol. 2006;186:687-695.
21. Pais SA, Attasaranya S, Leblanc JK, et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489-495.
22. Taouli B, Vilgrain V, Vullierme MP, et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology. 2000;217:757-764.
23. Fukukura Y, Fujiyoshi F, SasakiM, et al. HASTE MR cholangiopancreatography in the evaluation of intraductal papillary-mucinous tumors of the pancreas. J Comput Assist Tomogr. 1999;23:301-305.
24. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009;144:345-349; discussion 349-350.
25. Hwang DW, Jang J-Y, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: A 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012;397:93-102.
26. Jang J-Y, Kim S-W, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: Is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124-132.
27. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: The differential diagnosis from benign entities. Arch Surg. 2004;139:188-192.
28. Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: Clinicopathologic characteristics and long-Term follow-up after resection. World J Surg. 2008;32:271-278; discussion 279-280.
29. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: Differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628-634.
30. SadakariY, Ienaga J,KobayashiK, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39:232-236.
31. Woo SM, Ryu JK, Lee SH, et al. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients. Br J Surg. 2009;96:405-411.
32. Akita H, Takeda Y, Hoshino H, et al. Mural nodule in branch duct-Type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg. 2011;202: 214-219.
33. Arikawa S, Uchida M, Uozumi J, et al. Utility of multidetector row CT in diagnosing branch duct IPMNs of the pancreas compared with MR cholangiopancreatography and endoscopic ultrasonography. KurumeMed J. 2011;57: 91-100.
34. Carbognin G, Zamboni G, Pinali L, et al. Branch duct IPMTs: Value of crosssectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging. 2006;31:320-325.
35. Chiu SS, Lim JH, Lee WJ, et al. Intraductal papillary mucinous tumour of the pancreas: Differentiation of malignancy and benignancy by CT. Clin Radiol. 2006;61:776-783.
36. Fukukura Y, Fujiyoshi F, Sasaki M, et al. Intraductal papillary mucinous tumors of the pancreas: Thin-section helical CT findings. AJR Am J Roentgenol. 2000;174:441-447.
37. Hirono S, Tani M, Kawai M, et al. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:517-522.
38. Hwang DW, Jang J-Y, Lim C-S, et al. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: A suggested scoring formula. J Korean Med Sci. 2011;26:740-746.
39. Jang J-Y, Kim S-W, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas:when canwe operate or observe? Ann Surg Oncol. 2008;15:199-205.
40. Kawaguchi Y, Yasuda K, Cho E, et al. Differential diagnosis of intraductal papillary-mucinous tumor of the pancreas by endoscopic ultrasonography and intraductal ultrasonography. Dig Endosc. 2004;16:101-106.
41. Kubo H, Chijiiwa Y, Akahoshi K, et al. Intraductal papillary-mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol. 2001;96:1429-1434.
42. Liu Y, Lin X, Upadhyaya M, et al. Intraductal papillary mucinous neoplasms of the pancreas: Correlation of helical CT features with pathologic findings. Eur J Radiol. 2010;76:222-227.
43. Mimura T, Masuda A, Matsumoto I, et al. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol. 2010;44:e224-e229.
44. Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg. 2009;16:353-358.
45. Ogawa H, Itoh S, Ikeda M, et al. Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology. 2008;248:876-886.
46. Ohtsuka T, Kono H, Nagayoshi Y, et al. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012;151:76-83.
47. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759-1764.
48. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: Observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79; quiz 309-310.
49. SalviaR,Crippa S, Falconi M, et al.Branch-duct intraductal papillary mucinous neoplasms of the pancreas: To operate or not to operate? Gut. 2007;56:1086-1090.
50. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654.
51. SerikawaM, Sasaki T, Fujimoto Y, et al. Management of intraductal papillarymucinous neoplasm of the pancreas: Treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006;40:856-862.
52. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244-1249.
53. Takeshita K, Kutomi K, Takada K, et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. J Comput Assist Tomogr. 2008;32:191-197.
54. Wakabayashi T, Kawaura Y, Morimoto H, et al. Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findings. Pancreas. 2001;22:370-377.
55. Halligan S, Altman DG. Evidence-based practice in radiology: Steps 3 and 4-Appraise and apply systematic reviews and meta-Analyses. Radiology. 2007;243:13-27.
56. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009;6:e1000100.